MXPA03010363A - Metodo para tratar hipertension ocular y glaucoma. - Google Patents
Metodo para tratar hipertension ocular y glaucoma.Info
- Publication number
- MXPA03010363A MXPA03010363A MXPA03010363A MXPA03010363A MXPA03010363A MX PA03010363 A MXPA03010363 A MX PA03010363A MX PA03010363 A MXPA03010363 A MX PA03010363A MX PA03010363 A MXPA03010363 A MX PA03010363A MX PA03010363 A MXPA03010363 A MX PA03010363A
- Authority
- MX
- Mexico
- Prior art keywords
- glaucoma
- ocular hypertension
- treating ocular
- compound
- eye
- Prior art date
Links
- 208000010412 Glaucoma Diseases 0.000 title abstract 2
- 206010030043 Ocular hypertension Diseases 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000003190 augmentative effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003889 eye drop Substances 0.000 abstract 1
- 229940012356 eye drops Drugs 0.000 abstract 1
- 230000004410 intraocular pressure Effects 0.000 abstract 1
- 230000001603 reducing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29035501P | 2001-05-14 | 2001-05-14 | |
| PCT/JP2002/004600 WO2002092098A1 (en) | 2001-05-14 | 2002-05-13 | Method for treating ocular hypertension and glaucoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03010363A true MXPA03010363A (es) | 2004-03-16 |
Family
ID=23115609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03010363A MXPA03010363A (es) | 2001-05-14 | 2002-05-13 | Metodo para tratar hipertension ocular y glaucoma. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20050014837A1 (https=) |
| EP (1) | EP1390035A1 (https=) |
| JP (1) | JP2004529177A (https=) |
| KR (1) | KR20040008174A (https=) |
| CN (1) | CN1525861A (https=) |
| BR (1) | BR0209601A (https=) |
| CA (1) | CA2444627A1 (https=) |
| MX (1) | MXPA03010363A (https=) |
| NO (1) | NO20035043D0 (https=) |
| WO (1) | WO2002092098A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003215820A1 (en) * | 2002-03-28 | 2003-10-13 | Sucampo Ag | Method for treating ocular hypertension and glaucoma |
| US8580851B2 (en) | 2002-08-21 | 2013-11-12 | Sucampo Ag | Ophthalmic solution |
| WO2005018646A1 (ja) * | 2003-08-21 | 2005-03-03 | Sucampo Ag | 眼科用組成物 |
| AR043161A1 (es) * | 2003-02-14 | 2005-07-20 | Sucampo Pharmaceuticals Inc | Composicion oftalmica para tratar hipertension ocular y glaucoma |
| US12478503B2 (en) | 2009-05-18 | 2025-11-25 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
| US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
| US9061034B2 (en) | 2010-07-29 | 2015-06-23 | Allergan, Inc. | Preservative free bimatoprost and timolol solutions |
| US9078854B2 (en) | 2010-07-29 | 2015-07-14 | Allergan, Inc. | Preservative free bimatoprost and timolol solutions |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5212200A (en) * | 1987-09-18 | 1993-05-18 | R-Tech Ueno, Ltd. | Ocular hypotensive agents |
| US5208256A (en) * | 1990-05-22 | 1993-05-04 | R-Tech Ueno, Ltd. | Treatment of ocular hypertension with a synergistic combination for ocular administration |
| DE69232150T2 (de) * | 1992-03-19 | 2002-03-07 | R-Tech Ueno, Ltd. | Behandlung von Augenhochdruck mit Betablockern und Prostansäurederivaten |
| TW420611B (en) * | 1995-03-10 | 2001-02-01 | R Tech Ueno Ltd | Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder |
| ATE289817T1 (de) * | 1998-12-25 | 2005-03-15 | Sucampo Ag | Arzneimittelzusammenstellung zur behandlung des erhöhten augeninnendrucks oder des glaukom |
| US6458836B1 (en) * | 2000-03-16 | 2002-10-01 | Sucampo, A.G. | Treatment of ocular hypertension and glaucoma |
-
2002
- 2002-05-13 WO PCT/JP2002/004600 patent/WO2002092098A1/en not_active Ceased
- 2002-05-13 EP EP02724768A patent/EP1390035A1/en not_active Withdrawn
- 2002-05-13 BR BR0209601-3A patent/BR0209601A/pt not_active IP Right Cessation
- 2002-05-13 CN CNA028137566A patent/CN1525861A/zh active Pending
- 2002-05-13 MX MXPA03010363A patent/MXPA03010363A/es unknown
- 2002-05-13 US US10/477,359 patent/US20050014837A1/en not_active Abandoned
- 2002-05-13 KR KR10-2003-7014707A patent/KR20040008174A/ko not_active Withdrawn
- 2002-05-13 JP JP2002589015A patent/JP2004529177A/ja active Pending
- 2002-05-13 CA CA002444627A patent/CA2444627A1/en not_active Abandoned
-
2003
- 2003-11-13 NO NO20035043A patent/NO20035043D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1390035A1 (en) | 2004-02-25 |
| NO20035043D0 (no) | 2003-11-13 |
| JP2004529177A (ja) | 2004-09-24 |
| WO2002092098A1 (en) | 2002-11-21 |
| KR20040008174A (ko) | 2004-01-28 |
| US20050014837A1 (en) | 2005-01-20 |
| BR0209601A (pt) | 2004-03-23 |
| CA2444627A1 (en) | 2002-11-21 |
| CN1525861A (zh) | 2004-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1314220C (en) | Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure | |
| WO2002080811A3 (en) | Glaucoma stent and methods thereof for glaucoma treatment | |
| CA2440764A1 (en) | Combination of brimonidine and timolol for topical ophthalmic use | |
| MX9702349A (es) | Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma. | |
| WO2004026347A3 (en) | Apparatus and method for surgical bypass of aqueous humor | |
| PT868186E (pt) | Utilizacao de certos compostos de isoquinolinossulfonilo para tratamento de glaucoma e isquemia ocular | |
| EP1385452A4 (en) | DEVICE FOR ADMINISTERING OPHTHALMIC DRUG | |
| WO2002096318A3 (en) | Method for treating glaucoma v | |
| WO2003092584A3 (en) | Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies | |
| WO2001041685A3 (en) | Treatment of ocular disease | |
| WO2002089699A3 (en) | Medical device and methods of use for glaucoma treatment | |
| WO2009137085A3 (en) | Sustained release delivery of active agents to treat glaucoma and ocular hypertension | |
| WO2002062385A3 (en) | Method to prevent vision loss | |
| CA2502437A1 (en) | Method and composition containing latanoprost for treating ocular hypertension and glaucoma | |
| EP1545655A4 (en) | IMPLANTABLE OXULAR PUMP FOR REDUCING EYE REMINDER | |
| WO2006066103A3 (en) | Ophthalmic implant for treatment of glaucoma | |
| MXPA03006439A (es) | Metodo y composiciones novedosos para tratamiento local del mal del meniere, zumbido de oidos y/o perdida de oido. | |
| WO2002009702A8 (en) | Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure | |
| WO2000018316A3 (en) | Sustained release, and comfortable ophthalmic composition and method for ocular therapy | |
| ATE359794T1 (de) | 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes | |
| WO1998039293A3 (en) | 13-thia prostaglandins for use in glaucoma therapy | |
| MXPA03010363A (es) | Metodo para tratar hipertension ocular y glaucoma. | |
| CA2505086A1 (en) | Ophthalmic compositions for treating ocular hypertension | |
| MXPA03005922A (es) | Metodo para tratar glaucoma ib. | |
| US20060024349A1 (en) | Method for creating a separation of posterior cortical vitreous from the retina of the eye |